Guideline | Drug Name |
---|---|
Short Acting Insulin - ST, NF | Humalog (insulin lispro), Lyumjev (insulin lispro-aabc), Novolin (human insulin), Novolog (insulin aspart) |
Signifor, Signifor LAR (pasireotide) - PA, NF | Signifor (pasireotide), Signifor LAR (pasireotide) |
Siklos (hydroxyurea) | Siklos (hydroxyurea) |
Siliq (brodalumab) - PA, NF | Siliq (brodalumab) |
Simponi, Simponi Aria (golimumab) | Simponi (golimumab) - for subcutaneous use, Simponi Aria (golimumab) - for intravenous use |
Skin Cancer Agents | Klisyri (tirbanibulin) ointment |
Skyclarys (omaveloxolone) | Skyclarys (omaveloxolone) |
Skyrizi (risankizumab-rzaa) | Skyrizi IV (risankizumab-rzaa), Skyrizi SC (risankizumab-rzaa) |
Skysona (elivaldogene autotemcel suspension) - PA, NF | Skysona (elivaldogene autotemcel suspension) |
Soaanz (torsemide) | Soaanz (torsemide) |
Sodium Oxybate Containing Agents - PA, NF | Lumryz (sodium oxybate) extended-release oral solution, Xyrem (sodium oxybate) oral solution, Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution |
Sohonos (palovarotene) | Sohonos (palovarotene) |
Somatuline Depot (lanreotide) | Lanreotide Injection, Somatuline Depot (lanreotide) |
Somavert (pegvisomant) | Somavert (pegvisomant) |
Sotyktu (deucravacitinib) | Sotyktu (deucravacitinib) |
Sovaldi (sofosbuvir) | Sovaldi (sofosbuvir) |
Spevigo (spesolimab-sbzo) | Spevigo (spesolimab-sbzo) |
Spinraza (nusinersen) | Spinraza (nusinersen) |
Spravato (esketamine) - PA, NF | Spravato (esketamine) |
Sprycel (dasatinib) - PA, NF | Sprycel (dasatinib) |